These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20827721)

  • 1. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease.
    Targher G; Day CP
    Hepatology; 2011 Jan; 53(1):375. PubMed ID: 20827721
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
    Schindhelm RK; Heine RJ; Diamant M
    Diabetes Care; 2007 Sep; 30(9):e94; author reply e95. PubMed ID: 17726184
    [No Abstract]   [Full Text] [Related]  

  • 3. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
    Schindhelm RK; Diamant M; Dekker JM; Tushuizen ME; Teerlink T; Heine RJ
    Diabetes Metab Res Rev; 2006; 22(6):437-43. PubMed ID: 16832839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.
    Fan JG
    J Dig Dis; 2008 May; 9(2):63-7. PubMed ID: 18419637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease and diabetes mellitus.
    Adams LA
    Endocr Res; 2007; 32(3):59-69. PubMed ID: 18092195
    [No Abstract]   [Full Text] [Related]  

  • 6. [The association of cardiovascular risk factors with nonalcoholic fatty liver disease in health checkup examinees].
    Yu JH; Lee KS; Lee SY; Hong AR; Park YS
    J Prev Med Public Health; 2008 Nov; 41(6):407-12. PubMed ID: 19037170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease in type 2 diabetes mellitus.
    Cusi K
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):141-9. PubMed ID: 19262374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment implication from the potential association between nonalcoholic fatty liver disease and cardiovascular disease.
    Shen L
    Hepatology; 2011 Jul; 54(1):377-8. PubMed ID: 21710476
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin resistance links nonalcoholic fatty liver to cardiovascular diseases.
    Salamone F; Galvano F; Li Volti G
    Hepatology; 2011 May; 53(5):1785-6. PubMed ID: 21520192
    [No Abstract]   [Full Text] [Related]  

  • 10. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.
    Villanova N; Moscatiello S; Ramilli S; Bugianesi E; Magalotti D; Vanni E; Zoli M; Marchesini G
    Hepatology; 2005 Aug; 42(2):473-80. PubMed ID: 15981216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suggestion of a dual-functional agent for future trials in nonalcoholic fatty liver disease.
    Shen L
    Hepatology; 2010 Nov; 52(5):1866-7. PubMed ID: 20672381
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipids in the wrong place: visceral fat and nonalcoholic steatohepatitis.
    Perseghin G
    Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S367-70. PubMed ID: 21525484
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men.
    Shibata M; Kihara Y; Taguchi M; Tashiro M; Otsuki M
    Diabetes Care; 2007 Nov; 30(11):2940-4. PubMed ID: 17666460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
    Targher G; Bertolini L; Padovani R; Rodella S; Tessari R; Zenari L; Day C; Arcaro G
    Diabetes Care; 2007 May; 30(5):1212-8. PubMed ID: 17277038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study.
    Monami M; Bardini G; Lamanna C; Pala L; Cresci B; Francesconi P; Buiatti E; Rotella CM; Mannucci E
    Metabolism; 2008 Mar; 57(3):387-92. PubMed ID: 18249212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What do cancer, diabetes, and cardiovascular disease have in common?
    Van Horn L
    J Am Diet Assoc; 2009 Aug; 109(8):1329. PubMed ID: 19631034
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.
    Targher G; Day CP; Bonora E
    N Engl J Med; 2010 Sep; 363(14):1341-50. PubMed ID: 20879883
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease is a potential risk factor for cardiovascular diseases.
    Tao H; Shi KH; Wu JX; Zhan HY
    Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):e11-2. PubMed ID: 24444807
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolic syndrome as a precursor of diabetes mellitus type 2 and cardiovascular diseases].
    Shestakova MV; Butrova SA; Sukhareva OIu
    Ter Arkh; 2007; 79(10):5-8. PubMed ID: 18154136
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin resistance: cause or consequence of nonalcoholic steatohepatitis?
    Ahima RS
    Gastroenterology; 2007 Jan; 132(1):444-6. PubMed ID: 17241893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.